Machine learning model identifies diabetes in MAFLD with moderate accuracy
An interpretable model using liver, inflammatory, and metabolic markers may help flag coexisting type 2 diabetes in MAFLD, pending external validation.
Trials, guidelines and clinical evidence across Endocrinology.
Trials, guidelines and clinical evidence across Endocrinology.